Prevalence and changes in hepatitis C virus genotypes among multitransfused persons with hemophilia

Journal of Infectious Diseases

Volumn 179, Issue 5, 1999, Pages 1062-1069

  Eyster, M Elaine ^a,b,c,d   Sherman, Kenneth E ^a,b,c,d   Goedert, James J ^a,b,c,d   Katsoulidou, Antigoni ^a,b,c,d   Hatzakis, Angeles ^a,b,c,d  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; CHILD; CLINICAL ARTICLE; CONSENSUS SEQUENCE; FOLLOW UP; GENOTYPE; HEMOPHILIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; GENOTYPE; HEMOPHILIA A; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; IMMUNOASSAY; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; TIME FACTORS; VIREMIA;

EID: 0033009317     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314708     Document Type: Article

References (48)

1. 1. Makris M, Preston FE, Triger DR, et al. Hepatitis C antibody and chronic liver disease in haemophilia. Lancet 1990;335:1117-9.
2. 2. Brettler DB, Alter HJ, Dienstag JL, Forsberg AD, Levine PH. Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients. Blood 1990;76:254-6.
3. 3. Tedder R, Briggs M, Ring C, et al. Hepatitis C antibody profile and viraemia prevalence in adults with severe haemophilia. Br J Haematol 1991;79: 512-5.
4. 4. Watson HG, Ludlam CA, Rebus S, Zhang LQ, Peutherer JF, Simmonds P. Use of several second generation serological assays to determine the true prevalence of hepatitis C virus infection in haemophiliacs treated with non virus inactivated factor VIII and IX concentrates. Br J Haematol 1992;80:514-8.
5. 5. Troisi CL, Hollinger FB, Hoots WK, et al. A multicenter study of viral hepatitis in a United States hemophilic population. Blood 1993;81:412-8.
6. 6. Fletcher ML, Trowell JM, Craske J, Pavier K, Rizza CR. Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients. Br Med J (Clin Res Ed) 1983;287:1754-7.
7. 7. Kernoff PBA, Lee CA, Karayiannis P, Thomas HC. High risk of non-A non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin. Br J Haematol 1985;60:469-79.
8. 8. Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ. Natural history of hepatitis C virus (HCV) infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus (HIV). J Acquir Immune Defic Syndr 1993;6:602-10.
9. 9. Telfer P, Sabin C, Devereux H, Scott F, Dusheiko G, Lee C. The progression of HCV-associated liver disease in a cohort of haemophilic patients. Br J Haematol 1994;87:555-61.
10. 10. Eyster ME, Fried MW, DiBisceglie AM, Goedert JJ, for the Multicenter Hemophilia Cohort Study. Increasing HCV RNA levels in hemophiliacs: relationship to HIV infection and liver disease. Blood 1994;84:1020-3.
11. 11. Telfer PT, Brown D, Devereuz H, Lee CA, Dusheiko GM. HCV RNA levels and HIV infection: evidence for a viral interaction in haemophilic patients. Br J Haematol 1994;88:397-9.
12. 12. Ogata N, Alter HJ, Miller RH, Purcell RH. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 1991;88:3392-6.
13. 13. Martell M, Esteban JI, Quer J, et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992;66:3225-9.
14. 14. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995;15:41-63.
15. 15. Lau JYN, Davis GL, Prescott LE, Maertens G, Lindsay KL, Quan K. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Ann Intern Med 1996;124:868-76.
16. 16. Simmonds P, Holmes EC, Cha TA, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993;74:2391-9.
17. 17. Yoshioka K, Kakumu S, Wakita T, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992;16:293-9.
18. 18. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C. Hepatitis C virus type 1b (II) infection in France and Italy: Collaborative Study Group. Ann Intern Med 1995;122:161-8.
19. 19. Enomoto M, Sakuma I, Asahina Y, et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996;334:77-81.
20. 20. Mahaney K, Tedeschi V, Maertens G, DiBisceglie AM, Vergalla J, Hoofnagle JH. Genotype analysis of hepatitis C virus in American patients. Hepatology 1994;20:1405-11.
21. 21. Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Persing DH. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Ann Intern Med 1996;125: 634-9.
22. 22. Telfer PT, Devereux H, Savage K, et al. Chronic hepatitis C virus infection in haemophilic patients: clinical significance of viral genotype. Thromb Haemost 1995;74:1259-64.
23. 23. Goedert JJ, Kessler CM, Aledort LM, et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med 1989;321:1141-8.
24. 24. Eyster ME, Gail MH, Ballard JO, Al-Mondhiry H, Goedert JJ. Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. Ann Intern Med 1987; 107:1-6.
25. 25. Shindo M, DiBisceglie AM, Cheung L, et al. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 1991;115:700-4.
26. 26. Sherman KE, Mendenhall C, Thee DL, O'Brien J, Rouster SD. Hepatitis C serotypes in nonalcoholic and alcoholic patients. Dig Dis Sci 1997;42: 2285-91.
27. 27. Lau JYN, Simmonds P, Urdea MS. Implications of variations of "conserved" regions of hepatitis C virus genome. Lancet 1995;346:425-6.
28. 28. Lau JYN, Mizokami M, Kolberg JA, et al. Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis 1995;171:281-9.
29. 29. Jarvis LM, Ludlam CA, Ellender JA, et al. Investigation of the relative infectivity and pathogenicity of different hepatitis C virus genotypes in hemophiliacs. Blood 1996;87:3007-11.
30. 30. Devereux H, Telfer P, Brown D, et al. Longitudinal genotype analysis and quantification of hepatitis C virus in haemophilic patients receiving interferon-alpha therapy. J Viral Hepat 1996;3:43-8.
31. 31. Jarvis LM, Watson HG, McOmish F, et al. Frequent reinfection and reactivation of hepatitis C virus genotypes in multitransfused hemophiliacs. J Infect Dis 1994;170:1018-22.
32. 32. Eyster ME, Hatzakis A, Goedert JJ, for the Multicenter Hemophilia Study Group. HCV genotypes in multitransfused hemophiliacs. Blood 1996; 88(Suppl):526a.
33. 33. Tuveri R, Rothschild C, Pol S, et al. Hepatitis C virus genotypes in French haemophiliacs: kinetics and reappraisal of mixed infections. J Med Virol 1997;51:36-41.
34. 34. Devereux H, Telfer P, Dusheiko G, Lee C. Hepatitis C genotypes in haemophilic patients treated with alpha-interferon. J Med Virol 1995;45: 284-7.
35. 35. Kato N, Yokosuka O, Hosoda K, et al. Quantification of hepatitis C virus by competitive reverse transcription polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology 1993;18:16-20.
36. 36. Jarvis LM, Ludlam CA, Simmonds P. Hepatitis C virus genotypes in multitransfused individuals. Haemophilia 1995;1:3-7.
37. 37. Preston FE, Jarvis LM, Makris M, et al. Heterogeneity of hepatitis C virus genotypes in hemophilia: relationship with chronic liver disease. Blood 1995;85:1259-62.
38. 38. Isobe K, Imoto M, Fukuda Y, et al. Hepatitis C virus infection and genotypes in Japanese hemophiliacs. Liver 1995;15:131-4.
39. 39. Tagariello G, Pontisso P, Davoli PG, et al. Hepatitis C virus genotypes and severity of chronic liver disease in haemophiliacs. Br J Haematol 1995; 91:708-13.
40. 40. Fujimura Y, Ishimoto S, Shimoyama T, et al. Genotypes and multiple infections with hepatitis C virus in patients with haemophilia A in Japan. J Viral Hepat 1996;3:79-84.
41. 41. Takayama S, Taki M, Meguro T, Nishikawa K, Shiraki K, Yamada K. Virological characteristics of HCV infection in Japanese haemophiliacs. Haemophilia 1997;3:131-6.
42. 42. Tuveri R, Rothschild C, Pol S, et al. Hepatitis C virus genotypes in French haemophiliacs: kinetics and reappraisal of mixed infections. J Med Virol 1997;51:36-41.
43. 43. Toyoda H, Yoshihide F, Yassuo K, et al. Nucleotide sequence diversity of hypervariable region 1 of hepatitis C virus in Japanese hemophiliacs with chronic hepatitis C and patients with chronic posttransfusion hepatitis C. Blood 1996;88:1488-93.
44. 44. Sharara MD, Ala I, Hunt CM, Hamilton JD. Hepatitis C. Ann Intern Med 1996;125:658-68.
45. 45. Sherman KE, Andreatta C, O'Brien J, et al. Hepatitis C in human immunodeficiency virus coinfected patients: increased variability in the hypervariable envelope coding domain. Hepatology 1996;23:688-94.
46. 46. Honda M, Kaneko S, Sakai A, Unoura M, Murakami S, Kobayashi K. Degree of diversity of hepatitis C virus quasi-species and progression of liver disease. Hepatology 1994;20:1144-51.
47. 47. Okada S, Akahane Y, Suzuki H, Okamoto H, Mishiro S. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 1992;16:619-24.
48. 48. Kanazawa Y, Hayashi N, Mita E, et al. Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients. Hepatology 1994;20:1121-30.